CMG Pharmaceutical Co. Ltd (058820) — Cash Flow Reinvestment Rate
CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Reinvestment Rate of 113.83x as of December 2024, reinvesting ₩33.02 Billion (capex ₩31.75 Billion plus investments ₩1.27 Billion) from operating cash flow of ₩290.09 Million. See CMG Pharmaceutical Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CMG Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for CMG Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see 058820 operating cash flow.
Annual Cash Flow Reinvestment Rate for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year capital reinvestment analysis for CMG Pharmaceutical Co. Ltd. See CMG Pharmaceutical Co. Ltd (058820) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 301.60x | ₩87.49 Billion | ₩290.09 Million | ₩31.75 Billion | ▲ +2612.3% |
| 2023 | 11.12x | ₩43.47 Billion | ₩3.91 Billion | ₩15.25 Billion | ▲ +159.3% |
| 2022 | 4.29x | ₩21.18 Billion | ₩4.94 Billion | ₩10.31 Billion | ▲ +94.2% |
| 2021 | 2.21x | ₩12.43 Billion | ₩5.63 Billion | ₩3.95 Billion | ▼ -71.3% |
| 2020 | 7.70x | ₩22.66 Billion | ₩2.94 Billion | ₩9.65 Billion | ▼ -67.6% |
| 2019 | 23.77x | ₩67.12 Billion | ₩2.82 Billion | ₩8.18 Billion | ▲ +41.5% |
| 2018 | 16.81x | ₩14.90 Billion | ₩886.78 Million | ₩2.55 Billion | ▲ +1871.7% |
| 2017 | 0.85x | ₩1.66 Billion | ₩1.95 Billion | ₩760.59 Million | ▼ -96.3% |
| 2016 | 23.34x | ₩53.90 Billion | ₩2.31 Billion | ₩799.00 Million | ▲ +551.8% |
| 2015 | 3.58x | ₩8.64 Billion | ₩2.41 Billion | ₩3.64 Billion | ▼ -72.5% |
| 2014 | 13.02x | ₩9.44 Billion | ₩724.89 Million | ₩9.42 Billion | — |